Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15651-15700 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03570606
Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications.
N/AActive, not recruiting
220 participants
Started: Jun 13, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor7 locations
NCT06808672
Biomarkers of Cancer-Associated Myositis
N/AActive, not recruiting
50 participants
Started: Jun 13, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT03924856
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
PHASE3Active, not recruiting
907 participants
Started: Jun 13, 2019 · Completed: Sep 1, 2026
1 condition1 sponsor175 locations
NCT04005521
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients with Head and Neck Cancer
NAActive, not recruiting
80 participants
Started: Jun 13, 2019 · Completed: Jul 31, 2028
3 conditions1 sponsor1 location
NCT03571191
Denosumab Treatment for Fibrous Dysplasia
PHASE2Active, not recruiting
9 participants
Started: Jun 13, 2019 · Completed: Mar 15, 2030
2 conditions1 sponsor1 location
NCT05421442
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
N/AActive, not recruiting
1,450 participants
Started: Jun 13, 2019 · Completed: Jan 30, 2026
2 conditions1 sponsor1 location
NCT03988595
Exercise Treatment With Standard Therapy for Metastatic Breast Cancer
PHASE1Active, not recruiting
54 participants
Started: Jun 12, 2019 · Completed: Aug 1, 2026
1 condition1 sponsor10 locations
NCT03989947
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
PHASE2Active, not recruiting
73 participants
Started: Jun 12, 2019 · Completed: May 31, 2038
1 condition1 sponsor16 locations
NCT03865212
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
PHASE1Active, not recruiting
12 participants
Started: Jun 12, 2019 · Completed: Jan 20, 2027
13 conditions1 sponsor2 locations
NCT03972930
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
PHASE2Active, not recruiting
48 participants
Started: Jun 11, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03999749
A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
PHASE2Active, not recruiting
71 participants
Started: Jun 11, 2019 · Completed: Apr 7, 2030
1 condition1 sponsor4 locations
NCT03767244
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
PHASE3Active, not recruiting
2,517 participants
Started: Jun 11, 2019 · Completed: Jul 19, 2029
1 condition1 sponsor202 locations
NCT04089215
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
PHASE2Active, not recruiting
82 participants
Started: Jun 11, 2019 · Completed: Sep 30, 2024
3 conditions1 sponsor10 locations
NCT03992417
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
N/AActive, not recruiting
955 participants
Started: Jun 11, 2019 · Completed: Mar 31, 2027
1 condition2 sponsors114 locations
NCT03985176
Delayed Cerebral Ischaemia and Coagulation Alterations After Aneurysmal Subarachnoid Haemorrhage
N/AActive, not recruiting
62 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03973372
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
N/AActive, not recruiting
852 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2027
2 conditions16 sponsors14 locations
NCT03735667
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NAActive, not recruiting
1,948 participants
Started: Jun 10, 2019 · Completed: Sep 30, 2034
1 condition1 sponsor75 locations
NCT03975907
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
PHASE1/PHASE2Active, not recruiting
121 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition14 sponsors23 locations
NCT03741101
Treatment of NF1-related Plexiform Neurofibroma With Trametinib
PHASE2Active, not recruiting
15 participants
Started: Jun 10, 2019 · Completed: Dec 15, 2024
3 conditions2 sponsors1 location
NCT03911557
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
PHASE2Active, not recruiting
14 participants
Started: Jun 8, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03839342
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
PHASE2Active, not recruiting
26 participants
Started: Jun 7, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03627988
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
PHASE2Active, not recruiting
65 participants
Started: Jun 7, 2019 · Completed: May 31, 2026
1 condition1 sponsor2 locations
NCT03793166
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
PHASE3Active, not recruiting
1,175 participants
Started: Jun 7, 2019 · Completed: Sep 15, 2026
9 conditions1 sponsor864 locations
NCT03943173
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
EARLY_PHASE1Active, not recruiting
15 participants
Started: Jun 7, 2019 · Completed: Dec 27, 2025
31 conditions2 sponsors1 location
NCT03965325
FOcUs on Colorectal CAncer oUtcomes: Long-Term Study
N/AActive, not recruiting
133 participants
Started: Jun 7, 2019 · Completed: Jun 6, 2025
1 condition1 sponsor1 location
NCT04040530
Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours
N/AActive, not recruiting
187 participants
Started: Jun 7, 2019 · Completed: Feb 7, 2026
2 conditions3 sponsors2 locations
NCT04088292
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
PHASE3Active, not recruiting
210 participants
Started: Jun 6, 2019 · Completed: Nov 30, 2024
1 condition5 sponsors4 locations
NCT03779711
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
PHASE2Active, not recruiting
95 participants
Started: Jun 6, 2019 · Completed: Feb 28, 2026
1 condition9 sponsors8 locations
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
N/AActive, not recruiting
2,800 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2027
1 condition9 sponsors3 locations
NCT03625752
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
NAActive, not recruiting
60 participants
Started: Jun 6, 2019 · Completed: May 7, 2026
2 conditions2 sponsors2 locations
NCT04302220
Myopic Optic Neuropathy in Chinese High Myopia Population
N/AActive, not recruiting
813 participants
Started: Jun 6, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03923270
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
PHASE1Active, not recruiting
25 participants
Started: Jun 6, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04870866
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
PHASE2Active, not recruiting
13 participants
Started: Jun 5, 2019 · Completed: Jun 16, 2027
1 condition9 sponsors2 locations
NCT03959215
Back in the Game: a Smartphone Application to Support Athletes Returning to Sport After Serious Injury
NAActive, not recruiting
169 participants
Started: Jun 5, 2019 · Completed: Jul 31, 2024
1 condition6 sponsors7 locations
NCT03598309
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
PHASE2Active, not recruiting
19 participants
Started: Jun 5, 2019 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT03766009
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
NAActive, not recruiting
627 participants
Started: Jun 5, 2019 · Completed: Dec 15, 2026
4 conditions3 sponsors58 locations
NCT03889795
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
PHASE1Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT03719131
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
PHASE2Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Jun 30, 2026
8 conditions2 sponsors1 location
NCT03612232
Cabozantinib in Advanced Adrenocortical Carcinoma
PHASE2Active, not recruiting
37 participants
Started: Jun 4, 2019 · Completed: Apr 30, 2025
1 condition1 sponsor2 locations
NCT03969004
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
PHASE3Active, not recruiting
415 participants
Started: Jun 4, 2019 · Completed: Mar 26, 2028
1 condition1 sponsor166 locations
NCT03727880
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
PHASE2Active, not recruiting
36 participants
Started: Jun 4, 2019 · Completed: Jan 15, 2026
2 conditions3 sponsors3 locations
NCT03915951
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
PHASE2Active, not recruiting
98 participants
Started: Jun 4, 2019 · Completed: Oct 30, 2025
1 condition1 sponsor159 locations
NCT03964311
Risk for Short-term Adverse Events in Older Emergency Department Users
NAActive, not recruiting
5,000 participants
Started: Jun 4, 2019 · Completed: Jan 1, 2025
4 conditions1 sponsor1 location
NCT03995966
A Clinical Trial for Self-Injurious Behavior
NAActive, not recruiting
16 participants
Started: Jun 4, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03913949
A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
PHASE1Active, not recruiting
74 participants
Started: Jun 3, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors5 locations
NCT03924219
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
N/AActive, not recruiting
120 participants
Started: Jun 3, 2019 · Completed: Jul 31, 2025
4 conditions2 sponsors12 locations
NCT03568383
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
PHASE3Active, not recruiting
5,832 participants
Started: Jun 3, 2019 · Completed: Jan 11, 2027
1 condition3 sponsors31 locations
NCT03775265
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
PHASE3Active, not recruiting
475 participants
Started: Jun 3, 2019 · Completed: Jun 1, 2027
4 conditions1 sponsor366 locations
NCT03907735
Oxytocin Receptor Expression in Pregnancy
N/AActive, not recruiting
30 participants
Started: Jun 3, 2019 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT03677739
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NAActive, not recruiting
1,160 participants
Started: Jun 3, 2019 · Completed: Dec 31, 2025
22 conditions2 sponsors2 locations